You are here: Industry Insights > serology test

News List

Quest Diagnostics Introduces New COVID-19 Semi-quantitative Serology Test Service americanpharmaceuticalreview
March 01, 2021
Quest Diagnostics has introduced a new COVID-19 testing service that aids in providing insight into an individual's immune response as a result of a recent or prior infection with SARS-CoV-2, the virus that causes COVID-19, or to immune response ...
ProterixBio Announces Commercial Availability COVID-19 Serology Test from Finger Stick americanpharmaceuticalreview
February 24, 2021
ProterixBio has announced commercial availability of a quantitative COVID-19 serology assay that has been validated for dried blood spots (DBS) from a finger stick.
Bio-Techne, Kantaro Biosciences to Launch Quantitative Research Use Only COVID-19 Serology Test americanpharmaceuticalreview
August 11, 2020
Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate Kantaro Biosciences, announced the anticipated launch of the COVID-SeroIndex, a Kantaro Quantitative SARS-CoV-2 IgG Antibody RUO kit.
FDA Authorizes First Tests that Estimate Antibodies from Past SARS-CoV-2 Infection americanpharmaceuticalreview
August 10, 2020
The U.S. Food and Drug Administration (FDA) authorized the first two COVID-19 serology tests that display an estimated quantity of antibodies present in the individual’s blood.
Biomerica Receives CE Mark for 10 Minute COVID-19 Exposure Test americanpharmaceuticalreview
May 08, 2020
Biomerica has received a CE mark and launched a new high-volume production version of its COVID-19 IgG/IgM Rapid Test (a finger prick blood test with results in 10 minutes.